Tobias Brandt

Senior Scientist, Viral Vector Process Development • CSL Behring

Tobias Brandt is leading the lentiviral vector downstream process development team at CSL Behring. After joining CSL’s recombinant protein team in 2016, Tobias started to build up the lentiviral process development labs at CSL’s Marburg site. Besides process development, Tobias is responsible for downstream scale-up and process transfer to manufacturing sites as well as biosafety.

Tobias acquired his PhD in Biological Sciences from the University of Cambridge, UK, and the MRC Laboratory of Molecular Biology and holds a diploma in Chemistry from the University of Marburg, Germany. Before joining CSL, Tobias worked as a post-doctoral researcher at the Max-Planck Institute for Biophysics, Frankfurt, Germany, concentrating on structural biology research of mitochondria using cryo-electron microscopy.


Also speaking

Theres Oakes

Head of Product Characterisation • Achilles Therapeutics

Pedro Silva Couto

Post Doctoral Research Fellow • UCL

Karen Moniz

Technical Director • ICCBBA

Event Info


Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.